Seaport Therapeutics SPTX
NASDAQ SPTX
$19.12 -0.86 (-4.30%)
At close: Nov 16, 2026 · 4:00 PM EST

Seaport Therapeutics (SPTX) Asset Utilization Ratio (2026)

Updated

Seaport Therapeutics' Asset Utilization Ratio was 0.03 in Q3 2026, down 14.2% from the prior quarter.

Analysis

Seaport Therapeutics (SPTX) Asset Utilization Ratio (2026) Analysis & Trends

For FY2025, Asset Utilization Ratio at Seaport Therapeutics came in at 0.04.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 0.60
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 0.50
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 0.47
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 0.51
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 0.50
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 0.41
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 0.62
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 0.31
10 Seaport Therapeutics 1.03 Bn 63.31 Mn - 0.03
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 0.03
Jun 30, 2026 0.03
Mar 31, 2026 0.04
API Access

Seaport Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=SPTX&period=max&api_key=YOUR_API_KEY